Lightstone closes $250M fund

On Sept. 20, Lightstone Ventures (Menlo Park, Calif.) closed Lightstone Ventures II at $250 million. Lightstone said the fund will invest $15-$20 million in each of about 15 early stage biotech and medical device companies. The fund has invested in one undisclosed company and participated in a $30 million series A round for Disarm Therapeutics Inc. (Cambridge, Mass.)...